维普期刊资源整合服务平台（V6.5）

105篇 您的检索式：作者名="Morgan TR"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease显示文摘	Lok AS Seeff LB Morgan TR		Gastroenterology0，，：	2
2	Epidemiotogy of alcoholic liver disease显示文摘	Mandayam S Jamal MM Morgan TR	2004	Seminars in liver disease2004，24，：	1
3	Interest of low inflation schedules and extended coverage of anti-G suit associated with PBG (Abstract)显示文摘	Morgan TR McKenzie I	1994	Aviat Space Environ Med1994，65，5：	1
4	Peginterferon -alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose显示文摘	HADZIYANNIS SJ SETTE HJr MORGAN TR	2004	Ann Intem Med2004，140，5：	1
5	Peginter-feron - alpha 2a and ribavirin combination therapy in chronichepatitis C: a randomized study of treatment duration and ribavi-rin dose显示文摘	HADZIYANNIS SJ SETTE H JR MORGAN TR	2004	Ann Intern Med2004，140，5：	1
6	COMBAT EDGE/ATAGS effect on fighter pilot G tolerance during centrifuge demonstration (Abstract)显示文摘	Morgan TR Shaffstall RM	1995	Aviat Space Environ Med1995，66，5：	1
7	Outcome of sus- tained virological responders with histologically advanced chronic hepatitis C显示文摘	MORGAN TR GHANY MG KIM HY	2010	Hepatology2010，52，3：	1
8	Incidence of hepatocellularcarcinoma and associated risk factors in hepatitis C-relatedadvanced liver disease显示文摘	Lok AS Seeff LB Morgan TR	2009	Gastroenterology2009，136，1：	1
9	Peginterferon alpha -2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose显示文摘	Hadziyannis S J Sette H J Morgan TR	2004	Ann Intern Med2004，140，5：	1
10	Peginterferon- alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose 显示文摘	Hadziyannis SJ Sette H Morgan TR	2004	Ann Intern Med2004，140，：	1
11	Impact of riBavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/riBavirin treatment显示文摘	Reddy KR Shiffman ML Morgan TR		Clinical Gastroenterology and Hepatology0，，：	1
12	Ascites fluid anlysis in ma-lignancy-related ascites 显示文摘	Runyon BA Hoefs JC Morgan TR	1988	Hepatology1988，8，5：	1
13	Production of a cytochrome P4502EI transgenic mouse and initial evaluation of alcoholic liver damage 显示文摘	Morgan K French SW Morgan TR	2002	Herpetology2002，36，1：	1
14	Peginterferon- a2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose 显示文摘	Hadziyannis SJ Sette H Jr Morgan TR Balan V Diago M Marcellin P Ramadori G Bodenheimer H Jr Bernstein D Rizzetto M Zeuzem S Pockros PJ Lin A Ackrill AM PEGASYS International Study Group	2004	Ann Intern Med2004，140，5：	1
15	Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis显示文摘	Lieber CS Weiss DG Morgan TR	2006	Am J Gastroenterol2006，101，7：	1
16	Colchicine does not prolong life in patients with advanced alcoholic cirrhpsis:results of a prospective,randomized,placebo-controlled,multicenter VA trial显示文摘	MORGAN TR NEMCHAUSKY N SCHIFF E	2002	Gastroenterology2002，122，：	1
17	Alcohol and hepatocellular carcinoma显示文摘	Morgan TR Mandayam S Jamal MM	2004	Gastroenterology2004，127，：	1
18	Production of a cytoehrome P450 2El transgenic mouse and initial evaluation of alcoholic liver damage显示文摘	Morgan K French SW Morgan TR	2002	Hepatology2002，36，1：	1
19	Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C:a randomized study of treatment duration and ribavirin dose显示文摘	HADZIYANNIS SJ SETTE H JR MORGAN TR	2004	Ann Intern Med2004，140，：	1
20	Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats显示文摘	Kunig AM Balasubramaniam V Markham NE Morgan D Montgomery G Grover TR	2005	Am J Physiol Lung Cell Mol Physiol2005，289，4：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示